Senores Pharmaceuticals schedules board meeting on May 14, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Trading window for insiders has been closed since April 1, 2026 and will remain closed until 48 hours after results declaration.
Disclosure made pursuant to SEBI Listing Obligations and Disclosure Requirements Regulation 29.